Predominant Role for Directly Transfected Dendritic Cells in Antigen Presentation to CD8+ T Cells after Gene Gun Immunization

Cutaneous gene (DNA) bombardment results in substantial expression of the encoded antigen in the epidermal layer as well as detectable expression in dendritic cells (DC) in draining lymph nodes (LNs). Under these conditions, two possible modes of DC antigen presentation to naive CD8+ T cells might exist: (a) presentation directly by gene-transfected DC trafficking to local lymph nodes, and (b) cross-presentation by untransfected DC of antigen released from or associated with transfected epidermal cells. The relative contributions of these distinct modes of antigen presentation to priming for cytotoxic T cell (CTL) responses have not been clearly established. Here we show that LN cells directly expressing the DNA-encoded antigen are rare; 24 h after five abdominal skin bombardments, the number of these cells does not exceed 50–100 cells in an individual draining LN. However, over this same time period, the total number of CD11c+ DC increases more than twofold, by an average of 20,000–30,000 DC per major draining node. This augmentation is due to gold bombardment and is independent of the presence of plasmid DNA. Most antigen-bearing cells in the LNs draining the site of DNA delivery appear to be DC and can be depleted by antibodies to an intact surface protein encoded by cotransfected DNA. This finding of predominant antigen presentation by directly transfected cells is also consistent with data from studies on cotransfection with antigen and CD86-encoding DNA, showing that priming of anti-mutant influenza nucleoprotein CTLs with a single immunization is dependent upon coexpression of the DNAs encoding nucleoprotein and B7.2 in the same cells. These observations provide insight into the relative roles of direct gene expression and cross-presentation in CD8+ T cell priming using gene gun immunization, and indicate that augmentation of direct DC gene expression may enhance such priming.

[1]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[2]  M. Albert,et al.  Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs , 1998, Nature.

[3]  A. Rosenberg,et al.  Contribution of cells at the site of DNA vaccination to the generation of antigen-specific immunity and memory. , 1998, Journal of immunology.

[4]  R. Steinman,et al.  Antigen Presentation by Dendritic Cells after Immunization with DNA Encoding a Major Histocompatibility Complex Class II–restricted Viral Epitope , 1997, The Journal of experimental medicine.

[5]  H. Herweijer,et al.  High expression of naked plasmid DNA in muscles of young rodents. , 1997, Human molecular genetics.

[6]  K. Shortman,et al.  Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. , 1997, Journal of immunology.

[7]  A. Iwasaki,et al.  The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. , 1997, Journal of immunology.

[8]  N. Restifo,et al.  Identification of a Kb-restricted CTL epitope of beta-galactosidase: potential use in development of immunization protocols for "self" antigens. , 1997, Methods.

[9]  J. Ulmer,et al.  Priming of Cytotoxic T Lymphocytes by DNA Vaccines: Requirement for Professional Antigen Presenting Cells and Evidence for Antigen Transfer from Myocytes , 1997, Molecular medicine.

[10]  A. Iwasaki,et al.  Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. , 1997, Journal of immunology.

[11]  A. Iwasaki,et al.  Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. , 1997, Journal of immunology.

[12]  D. Klatzmann,et al.  Three populations of mouse lymph node dendritic cells with different origins and dynamics. , 1997, Journal of immunology.

[13]  F. Marincola,et al.  Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Simon C Watkins,et al.  DNA–based immunization by in vivo transfection of dendritic cells , 1996, Nature Medicine.

[15]  D. Carson,et al.  Gene vaccination with naked plasmid DNA: mechanism of CTL priming , 1996, The Journal of experimental medicine.

[16]  J. Ulmer,et al.  Generation of MHC class I‐restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non‐muscle cells , 1996, Immunology.

[17]  C. Walker,et al.  Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  E. Raz,et al.  Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization , 1996, Science.

[19]  J. Berzofsky,et al.  Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes. , 1996, Journal of immunology.

[20]  S. Hoffman,et al.  Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity , 1996, The Journal of experimental medicine.

[21]  L. Goldsmith,et al.  A model for keratinocyte gene therapy: preclinical and therapeutic considerations. , 1996, Proceedings of the Association of American Physicians.

[22]  S. Rosenberg,et al.  Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. , 1996, Journal of immunology.

[23]  R. Steinman,et al.  The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing , 1995, Nature.

[24]  Z. Xiang,et al.  Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. , 1995, Immunity.

[25]  M. Kleijmeer,et al.  Antigen-bearing Langerhans cells in skin draining lymph nodes: phenotype and kinetics of migration. , 1994, The Journal of investigative dermatology.

[26]  E. Jaffee,et al.  Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. , 1994, Science.

[27]  D. Fuller,et al.  Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. , 1993, DNA and cell biology.

[28]  J. Ulmer,et al.  Heterologous protection against influenza by injection of DNA encoding a viral protein. , 1993, Science.

[29]  S. Johnston,et al.  Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. Acsadi,et al.  Direct gene transfer into mouse muscle in vivo. , 1990, Science.

[31]  M. Bevan,et al.  Class I-restricted processing and presentation of exogenous cell- associated antigen in vivo , 1990, The Journal of experimental medicine.

[32]  S. Knight,et al.  Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies , 1987, The Journal of experimental medicine.

[33]  M. Bevan,et al.  Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. , 1976, Journal of immunology.

[34]  R. Steinman,et al.  Dendritic cells as antigen-presenting cells in vivo. , 1997, Immunology and cell biology.

[35]  R. Webster,et al.  DNA vaccines. , 1996, AIDS research and human retroviruses.

[36]  E. Coligan Current protocols in immunology , 1991 .